Phibro Animal Health (NASDAQ:PAHC) Stock Price Down 5% Following Insider Selling

Phibro Animal Health Corporation (NASDAQ:PAHC) was down 5% during mid-day trading on Friday after an insider sold shares in the company. The stock traded as low as $40.58 and last traded at $39.5260. Approximately 9,657 shares changed hands during mid-day trading, a decline of 95% from the average daily volume of 184,352 shares. The stock had previously closed at $41.61.

Specifically, CEO Jack Bendheim sold 13,158 shares of the company’s stock in a transaction that occurred on Thursday, January 22nd. The stock was sold at an average price of $41.98, for a total transaction of $552,372.84. Following the sale, the chief executive officer owned 18 shares in the company, valued at $755.64. This represents a 99.86% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Also, CEO Jack Bendheim sold 14,687 shares of Phibro Animal Health stock in a transaction that occurred on Wednesday, January 21st. The stock was sold at an average price of $41.68, for a total value of $612,154.16. Following the completion of the transaction, the chief executive officer owned 29,838 shares of the company’s stock, valued at approximately $1,243,647.84. The trade was a 32.99% decrease in their position. The SEC filing for this sale provides additional information.

Wall Street Analysts Forecast Growth

PAHC has been the topic of several research analyst reports. Zacks Research upgraded Phibro Animal Health from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, December 9th. JPMorgan Chase & Co. increased their target price on shares of Phibro Animal Health from $45.00 to $50.00 and gave the stock an “overweight” rating in a report on Friday, November 7th. Finally, Weiss Ratings reaffirmed a “buy (b-)” rating on shares of Phibro Animal Health in a report on Monday, December 29th. One equities research analyst has rated the stock with a Strong Buy rating, two have given a Buy rating, two have assigned a Hold rating and two have given a Sell rating to the stock. Based on data from MarketBeat.com, Phibro Animal Health has an average rating of “Hold” and an average price target of $31.40.

Phibro Animal Health Trading Down 6.2%

The company has a current ratio of 3.09, a quick ratio of 1.35 and a debt-to-equity ratio of 2.32. The firm has a 50-day moving average of $40.16 and a 200 day moving average of $37.52. The stock has a market capitalization of $1.58 billion, a price-to-earnings ratio of 23.50, a PEG ratio of 1.10 and a beta of 0.79.

Phibro Animal Health (NASDAQ:PAHC) last issued its quarterly earnings results on Wednesday, November 5th. The company reported $0.73 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.58 by $0.15. Phibro Animal Health had a return on equity of 36.26% and a net margin of 4.85%.The company had revenue of $363.89 million for the quarter, compared to the consensus estimate of $345.44 million. Phibro Animal Health has set its FY 2026 guidance at 2.640-2.810 EPS. As a group, equities analysts predict that Phibro Animal Health Corporation will post 1.95 EPS for the current fiscal year.

Phibro Animal Health Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Wednesday, December 17th. Shareholders of record on Wednesday, November 26th were given a $0.12 dividend. This represents a $0.48 annualized dividend and a yield of 1.2%. The ex-dividend date was Wednesday, November 26th. Phibro Animal Health’s dividend payout ratio (DPR) is currently 28.92%.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently made changes to their positions in the stock. Farther Finance Advisors LLC lifted its stake in shares of Phibro Animal Health by 113.2% in the fourth quarter. Farther Finance Advisors LLC now owns 727 shares of the company’s stock valued at $27,000 after buying an additional 386 shares during the period. Hughes Financial Services LLC acquired a new position in Phibro Animal Health in the 3rd quarter valued at approximately $40,000. iSAM Funds UK Ltd acquired a new position in Phibro Animal Health in the 3rd quarter valued at approximately $61,000. EverSource Wealth Advisors LLC lifted its position in shares of Phibro Animal Health by 7,671.4% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 2,720 shares of the company’s stock worth $69,000 after acquiring an additional 2,685 shares during the period. Finally, Advisory Services Network LLC acquired a new stake in shares of Phibro Animal Health during the 3rd quarter worth approximately $96,000. Institutional investors own 99.34% of the company’s stock.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation (NASDAQ: PAHC) is a diversified global animal health and mineral nutrition company headquartered in Teaneck, New Jersey. The company develops, manufactures and markets a broad range of pharmaceutical, mineral nutrition and performance products designed to support the health and productivity of livestock, companion animals and aquaculture species. Phibro’s portfolio includes vaccines, anti-infective therapies, coccidiostats, disinfectants, premix minerals and specialty feed additives aimed at enhancing growth, immunity and overall animal well-being.

The company operates through three principal business segments: Animal Health, Mineral Nutrition and Performance Products.